M A Rodger

Summary

Affiliation: Ottawa Health Research Institute
Country: Canada

Publications

  1. ncbi request reprint The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy
    Marc A Rodger
    University of Ottawa, Ottawa, ON, Canada
    Thromb Res 112:13-8. 2003
  2. ncbi request reprint Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)
    Marc A Rodger
    The Ottawa Hospital, Centre for Practice Changing Research, 501 Smyth Road, Box 201, Ottawa, ON K1H 8 L6, Canada
    Syst Rev 3:69. 2014
  3. doi request reprint Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study
    Esteban Gandara
    Dr Marc Rodger, Division of Hematology, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada, Fax 1 613 739 6102, E mail
    Thromb Haemost 110:1172-9. 2013
  4. pmc Diagnostic randomized controlled trials: the final frontier
    Marc Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, ON, Canada
    Trials 13:137. 2012
  5. doi request reprint An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 131:S25-7. 2013
  6. doi request reprint Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial
    Marc A Rodger
    The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 60:427-34. 2012
  7. pmc Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis
    Alejandro Lazo-Langner
    Department of Medicine, University of Western Ontario, London ON, Canada
    BMC Med Res Methodol 12:3. 2012
  8. pmc Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 7:21. 2007
  9. doi request reprint Evidence base for the management of venous thromboembolism in pregnancy
    Marc Rodger
    Ottawa Hospital, Ottawa Hospital Research Institute, and University of Ottawa, Ottawa, Ontario, Canada
    Hematology Am Soc Hematol Educ Program 2010:173-80. 2010
  10. ncbi request reprint Do thrombophilias cause placenta-mediated pregnancy complications?
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Semin Thromb Hemost 33:597-603. 2007

Detail Information

Publications54

  1. ncbi request reprint The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy
    Marc A Rodger
    University of Ottawa, Ottawa, ON, Canada
    Thromb Res 112:13-8. 2003
    ..The aim of this study is to determine if some or all of these cost savings to third party payers are shifted to patients and their families...
  2. ncbi request reprint Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)
    Marc A Rodger
    The Ottawa Hospital, Centre for Practice Changing Research, 501 Smyth Road, Box 201, Ottawa, ON K1H 8 L6, Canada
    Syst Rev 3:69. 2014
    ..The project is called AFFIRM, An individual patient data meta-analysis oF low-molecular-weight heparin For prevention of placenta-medIated pRegnancy coMplications...
  3. doi request reprint Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study
    Esteban Gandara
    Dr Marc Rodger, Division of Hematology, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada, Fax 1 613 739 6102, E mail
    Thromb Haemost 110:1172-9. 2013
    ..2-3.8). In conclusion, non-OO blood type is associated with a statistically significant and clinically relevant increased risk of recurrent VTE following discontinuation of anticoagulant therapy for a first episode of unprovoked VTE. ..
  4. pmc Diagnostic randomized controlled trials: the final frontier
    Marc Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, ON, Canada
    Trials 13:137. 2012
    ..Doing so will better ensure that patients are offered diagnostic procedures that will make a clinical difference...
  5. doi request reprint An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 131:S25-7. 2013
    ..Do thrombophilias cause placenta mediated pregnancy complications? Does low molecular weight heparin prevent recurrent placenta mediated pregnancy complications?..
  6. doi request reprint Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial
    Marc A Rodger
    The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 60:427-34. 2012
    ..Our primary objective was to compare whether tinzaparin and dalteparin differentially accumulate in HD patients...
  7. pmc Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis
    Alejandro Lazo-Langner
    Department of Medicine, University of Western Ontario, London ON, Canada
    BMC Med Res Methodol 12:3. 2012
    ....
  8. pmc Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 7:21. 2007
    ..Elastic compression stockings (ECS) could be helpful in preventing PTS; however, data on their effectiveness are scarce and conflicting...
  9. doi request reprint Evidence base for the management of venous thromboembolism in pregnancy
    Marc Rodger
    Ottawa Hospital, Ottawa Hospital Research Institute, and University of Ottawa, Ottawa, Ontario, Canada
    Hematology Am Soc Hematol Educ Program 2010:173-80. 2010
    ..Prevention requires an optimal balancing of absolute increased bleeding risk from pharmacologic thromboprophylaxis and the absolute benefit of reduced DVT and PE, which, while serious, are relatively uncommon...
  10. ncbi request reprint Do thrombophilias cause placenta-mediated pregnancy complications?
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Semin Thromb Hemost 33:597-603. 2007
    ....
  11. pmc The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Departments of Medicine, Obstetrics and Gynecology and Epidemiology Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
    PLoS Med 7:e1000292. 2010
    ..We undertook a systematic review and a meta-analysis of prospective cohort studies to estimate the association of maternal FVL or PGM carrier status and placenta-mediated pregnancy complications...
  12. doi request reprint Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE
    M A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Clinical Epidemiology Unit, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ottawa, Ontario, Canada
    Thromb Res 126:222-6. 2010
    ..We sought to determine if serum Lp(a) levels in patients with unprovoked VTE who discontinue anticoagulants after 5 to 7 months of therapy predict VTE recurrence in a prospective cohort study...
  13. ncbi request reprint The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism
    Marc A Rodger
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 116:101-7. 2005
    ..We sought to determine (for patients with suspected PE) the interobserver reliability of pretest probability assessment (by overall impression (gestalt) versus an explicit clinical model)...
  14. doi request reprint Anticoagulant prophylaxis for placenta mediated pregnancy complications
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Departments of Medicine, Obstetrics and Gynecology and Epidemiology Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 127:S76-80. 2011
    ....
  15. ncbi request reprint Normal functional protein S activity does not exclude protein S deficiency
    Marc A Rodger
    Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    Pathophysiol Haemost Thromb 33:202-5. 2003
    ..Functional PS activity testing should not be used as a screening test to eliminate free antigenic PS testing for the laboratory diagnosis of PS deficiency...
  16. ncbi request reprint Diagnosis and treatment of venous thromboembolism in pregnancy
    Marc A Rodger
    Department of Medicine, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    Best Pract Res Clin Haematol 16:279-96. 2003
    ..It highlights the poverty of research upon which to base clinical recommendations for this common problem yet offers practical but conservative approaches to patients with suspected and confirmed pregnancy-associated VTE...
  17. doi request reprint Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit
    M Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa Hospital, General Campus, Ottawa, Ont, Canada
    Blood Rev 24:171-8. 2010
    ....
  18. doi request reprint Inherited thrombophilia and pregnancy complications revisited
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Obstet Gynecol 112:320-4. 2008
    ....
  19. pmc Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ont
    CMAJ 179:417-26. 2008
    ..We sought to determine clinical predictors to identify patients who are at low risk of recurrent venous thromboembolism who could safely discontinue oral anticoagulants...
  20. ncbi request reprint Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial
    M A Rodger
    Ottawa Health Research Institute, University of Ottawa, Ottawa, ON, Canada
    J Thromb Haemost 5:1600-6. 2007
    ..The risk of decreased bone mineral density (BMD) with prophylactic dose long-term low-molecular-weight heparin (LMWH) is unknown...
  21. doi request reprint Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
    M J Kovacs
    Department of Hematology, London Health Sciences Centre, Victoria Hospital, London, Ontario, Canada
    J Thromb Haemost 8:1926-32. 2010
    ....
  22. ncbi request reprint Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism
    M A Rodger
    Department of Medicine, University of Ottawa, Ontario, Canada
    Am J Respir Crit Care Med 162:2105-8. 2000
    ..We conclude that ABG data alone or in combination with other clinical data are not useful in the assessment of suspected PE...
  23. doi request reprint Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis
    M Carrier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada
    J Thromb Haemost 9:1119-25. 2011
    ....
  24. doi request reprint Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence
    A Hamadah
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Thromb Haemost 9:2406-10. 2011
    ..Whether baseline imaging, conducted after completion of anticoagulation, helps in interpreting diagnostic testing in patients who subsequently have suspected recurrent VTE is unknown...
  25. ncbi request reprint Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism
    M J Kovacs
    Department of Medicine, London Health Sciences Centre, London, ON, Canada
    Clin Lab Haematol 28:9-13. 2006
    ..8% of initial protein C and protein S results were accurate. If protein C and protein S are measured at the time of diagnosis of acute venous thromboembolism, the majority of the results will be normal and false positives are uncommon...
  26. doi request reprint Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies
    M Carrier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Thromb Haemost 8:1716-22. 2010
    ..We sought to summarize the proportion of subsegmental PE diagnosed with single- and multiple-detectors CTPA and assess the safety of diagnostic strategies based on single- or multiple-detectors CTPA to exclude PE...
  27. ncbi request reprint The management of thrombophilia during pregnancy: a Canadian survey
    Marc A Rodger
    Department of Medicine, University of Ottawa, Ottawa, ON
    J Obstet Gynaecol Can 24:946-52. 2002
    ..To determine current Canadian practice patterns in the management of pregnant women with thrombophilia...
  28. ncbi request reprint Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex
    M Carrier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Kidney Int 73:213-9. 2008
    ..Our study suggests that IgG-specific PF4-H antibody formation is associated with increased mortality in hemodialysis patients...
  29. ncbi request reprint Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial
    Mark A Crowther
    McMaster University, Hamilton, Ontario, Canada
    Ann Intern Med 150:293-300. 2009
    ..Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain...
  30. ncbi request reprint Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolism
    M A Rodger
    Department of Medicine, University of Ottawa, Ontario, Canada
    Chest 120:115-9. 2001
    ..15, (2) a negative D-dimer result, and (3) the combination of a steady-state end-tidal AVDSf of < 0.15 and a negative D-dimer result. Study design: Prospective cohort study...
  31. ncbi request reprint Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients
    M T Betancourt
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ontario, Canada
    Acta Chir Belg 107:636-40. 2007
    ..Research is also underway to determine the predictive ability of these known VTE recurrence risk factors, combinations of these risk factors and their interrelationships as well as to actively search for additional potential predictors...
  32. ncbi request reprint The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
    A Lazo-Langner
    Division of Hematology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
    J Thromb Haemost 5:729-37. 2007
    ..Low-molecular-weight heparins (LMWH) have an antitumor effect in vitro and in experimental animal models of malignancy. Retrospective data suggest that it might improve survival in cancer patients...
  33. ncbi request reprint Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery
    Alejandro Lazo-Langner
    Department of Medicine, The University of Western Ontario, London, Ontario, Canada
    Clin Appl Thromb Hemost 15:316-26. 2009
    ..These issues should be explicitly explored in future trials evaluating new direct thrombin inhibitors...
  34. ncbi request reprint The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism
    Philip S Wells
    Department of Medicine, University of Ottawa, Ottawa Health Research Institute, Ontario, Canada
    Arch Intern Med 163:917-20. 2003
    ..We sought to determine the accuracy of the index in our population of patients...
  35. ncbi request reprint A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism
    Philip S Wells
    Departments of Medicine, University of Ottawa, Ottawa Health Research Institute, Ottawa, Ontario
    Arch Intern Med 165:733-8. 2005
    ..No published trials have compared LMWHs, and few studies have examined outpatient therapy for PE. Only tinzaparin sodium has demonstrated superiority to unfractionated heparin in a clinical trial...
  36. pmc Risk of subsequent thromboembolism for patients with pre-eclampsia
    Carl van Walraven
    Ottawa Health Research Institute, Ottawa, Canada K1Y 4E9
    BMJ 326:791-2. 2003
  37. ncbi request reprint The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Philip S Wells
    Department of Medicine, University of Ottawa and the Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Blood Coagul Fibrinolysis 17:533-8. 2006
    ..69 (95% confidence interval, 0.46-1.02) for the dominant model. Our results do not support an independent association of the FXIII Val34Leu polymorphism with idiopathic venous thromboembolism in our Caucasian Canadian study population...
  38. ncbi request reprint The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism
    Philip S Wells
    Department of Medicine, University of Ottawa, Canada
    Thromb Haemost 90:829-34. 2003
    ..33). The ACE D/D genotype was present in 25.3% of cases and 32.4% of controls for an adjusted odds ratio of 0.66 (95% CI = 0.433 to 0.997). We can conclude that the ACE D/D genotype is protective against idiopathic venous thromboembolism...
  39. ncbi request reprint Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study
    M A Rodger
    Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada Department of Medicine, The University of Ottawa, Ottawa, ON, Canada
    J Thromb Haemost 12:469-78. 2014
    ..Cohort studies have not supported this association but were underpowered to detect small effects...
  40. doi request reprint Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
    Marc Carrier
    University of Ottawa, Ottawa Hospital Research Institute, Ontario, Canada
    Ann Intern Med 152:578-89. 2010
    ..Case-fatality rates are important for assessing the risks and benefits of anticoagulation in patients with venous thromboembolism (VTE)...
  41. ncbi request reprint The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism
    Marc A Rodger
    University of Ottawa, Ottawa Health Research Institute, and Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada
    Arch Intern Med 166:181-7. 2006
    ....
  42. ncbi request reprint A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction
    Heather E A Howley
    University of Ottawa, Ottawa, Ontario, Canada
    Am J Obstet Gynecol 192:694-708. 2005
    ..The purpose of this study was to conduct a systematic review of the literature of studies that examined the association between factor V Leiden and/or prothrombin gene variant and intrauterine growth restriction...
  43. pmc Effect of an interactive voice response system on oral anticoagulant management
    Natalie Oake
    Clinical Epidemiology Program, Ottawa Health Research Institute, The Ottawa Hospital, Ottawa, ON K1Y 4E9
    CMAJ 180:927-33. 2009
    ..Monitoring oral anticoagulants is logistically challenging for both patients and medical staff. We evaluated the effect of adding an interactive voice response system to computerized decision support for oral anticoagulant management...
  44. doi request reprint Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis
    L A Castellucci
    Department of Medicine, The Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, ON, Canada
    J Thromb Haemost 12:344-8. 2014
    ..The risk of major bleeding in patients who have completed anticoagulation therapy for unprovoked venous thromboembolism (VTE) is unknown...
  45. doi request reprint Heparin-induced osteoporosis and pregnancy
    Genevieve Le Templier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Canada
    Curr Opin Pulm Med 14:403-7. 2008
    ..With increasing long-term low-molecular-weight heparin use, for a variety of indications, this was an important knowledge gap...
  46. ncbi request reprint The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis
    Marc Carrier
    Thrombosis Program, Division of Hematology, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 120:215-20. 2007
    ....
  47. ncbi request reprint Thrombophilia and the risk for hemodialysis vascular access thrombosis
    Greg A Knoll
    Division of Nephrology, Department of Medicine, University of Ottawa, Ontario, Canada K1H 7W9
    J Am Soc Nephrol 16:1108-14. 2005
    ..34 to 2.61). This study suggests that thrombophilia is associated with access thrombosis in dialysis patients. Large, multicenter, prospective cohort studies are needed to confirm the observations from this case-control study...
  48. doi request reprint A pilot study to assess the feasibility of a multicenter cluster randomized trial for the management of asymptomatic persons with a thrombophilia
    Philip S Wells
    University of Ottawa, ON, Canada
    J Genet Couns 18:475-82. 2009
    ..The question of the best educational approach in these patients remains unanswered. The value of testing and following asymptomatic carriers of probands with VTE and thrombophilia remains unknown...
  49. ncbi request reprint Overview of current venous thromboembolism protocols in hip reconstruction
    Alejandro Lazo-Langner
    Department of Medicine, University of Western Ontario, 800 Commissioners Road, E PO Box 5010 Room A2 401, London, ON N6A 5W9, Canada
    Orthop Clin North Am 40:427-36. 2009
    ..This article reviews the current evidence-based recommendations for anticoagulant prophylaxis after total-hip arthroplasty and provides insight into the current areas of active research and controversy...
  50. ncbi request reprint The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene
    Alejandro Lazo-Langner
    Division of Hematology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario Canada
    Blood 108:4052-8. 2006
    ..We concluded that low TGF-beta1 production haplotype is a risk factor for hemodialysis access thrombosis and that in the presence of the 4G/4G PAI-1 genotype there is an additional increase in risk...
  51. ncbi request reprint Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability
    Marc Carrier
    Department of Medicine, University of Ottawa, ON, Canada
    Thromb Res 117:469-74. 2006
    ..Non-Elisa D-dimer in combination with pre-test probability of suspected PE can safely exclude PE at the bedside. Pre-test probability can be assigned by gestalt or by using clinical models (Wells, Wicki, Rodger)...
  52. doi request reprint Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial
    David R Anderson
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
    JAMA 298:2743-53. 2007
    ..Ventilation-perfusion scanning has been largely replaced by CTPA in many centers despite limited comparative formal evaluations and concerns about CTPA's low sensitivity (ie, chance of missing clinically important pulmonary embuli)...
  53. ncbi request reprint Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section
    Marc A Rodger
    The Ottawa Hospital, Ottawa, Ontario, Canada
    Am J Obstet Gynecol 194:436-7. 2006
    ..Pelvic magnetic resonance venography may be a useful surrogate outcome in obstetric thromboprophylaxis studies but the clinical significance is not known...
  54. doi request reprint Inter-observer reliability of measures to assess the post-thrombotic syndrome
    Marc A Rodger
    Thromb Haemost 100:164-6. 2008